About 700 reports

  • Genomics biomarkers market in EMEA
  • Genomics biomarkers market in APAC

About Genomics Biomarkers A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of...

  • Genomics
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Roche Group
  • Thermo Fisher Scientific, Inc.
  • GENOMICS MARKET
  • GLOBAL GENOMICS MARKET, BY TECHNOLOGY

Genomics market is projected to grow at a CAGR of 10.2% The global genomics market is estimated to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 23.88 billion in 2022 from 14.71 billion in 2017. The key factors driving the growth of the overall genomics market include the growing demand for rise in research activities...

  • Genomics
  • North America
  • United States
  • Market Size
  • Thermo Fisher Scientific, Inc.

Sample preparation is generally complex, laborious and one of the most error-prone steps within scientific research.

  • Genomics
  • Proteomics
  • World
  • Increasing number of research activities on human genomics
  • Increasing number of research activities on human genomics

About Prenatal DNA Sequencing Prenatal DNA sequencing is the method of DNA sequencing where DNA isolated from the blood of pregnant women to reveal the full genetic code of a fetus. It is useful in detecting disorders such as Down syndrome, cystic fibrosis, thalassemia, and cancer. Technavio’s analysts forecast...

  • Genomics
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.
  • Synthetic Genomics
  • Synthetic Genomics: Key offerings

About Synthetic Biology Workstation The global synthetic biology workstation market is segmented by application into pharmaceutical and biotechnology, food and agriculture, biochemicals, biofuels, and others. The others segment comprises regenerative medicine: bioplastics, biopolymers, and rubber. Advances in molecular...

  • Genomics
  • World
  • Intrexon Corporation
  • Tecan Group
  • Thermo Fisher Scientific, Inc.
  • CANCER BIOMARKERS MARKET FOR GENOMICS, BY TYPE, 2015-2022 (USD MILLION)
  • ASIA PACIFIC: CANCER BIOMARKERS MARKET FOR GENOMICS, BY COUNTRY, 2015-2022 (USD MILLION)

“Global cancer biomarkers market projected to grow at CAGR of 12.2%” The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence...

  • Genomics
  • North America
  • United States
  • World
  • Market Size
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“Clinical Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Date: April 3, 2017 Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion...

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“In Vitro Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially...

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size
  • 4.7 TAKARA BIO USA HOLDINGS AND RUBICON GENOMICS ANNOUNCE MERGER AGREEMENT
  • 3.5 DIAGNOSTIC TECHNOLOGY DEVELOPMENT

“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics....

  • Biomarker
  • Genomics
  • Molecular Diagnostic
  • United States
  • Market Size

Key players contributing in this market are BGI, Illumina, Inc, Pathway Genomics, Genesis Genetics, ##andMe, Inc, ARUP Laboratories, Color Genomics Inc., and Myriad Genetics, Inc.

  • Genetic
  • Genomics
  • United States
  • Demand
  • Market Size
  • 14.3 PATHWAY GENOMICS
  • 14.14 GENOMIC HEALTH

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Genomics
  • World
  • Forecast
  • Market Size
  • MDxHealth SA

Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024.

  • Biochip
  • Bioinformatic
  • Genomics
  • United States
  • Demand

Genomics In Cancer Care Market Analysis Table of Content Chapter ##.

  • Cancer
  • Genomics
  • Pathology
  • United States
  • Demand
  • 7.2.4.2 GENOMICS
  • Microfluidic Market: Revenue in USD million, by Lab Analytics, Genomics, Global, 2015-2023

The global microfluidics market was valued at USD 4.552 billion in 2017, and is expected to reach USD 111.95 billion by 2023, recording a CAGR of 17.45% over the forecast period of 2018-2023. The scope of the report is limited to solutions offered by major players, including providers of microfluidic chips, micro pumps, and micro needles....

  • Genomics
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Danaher Corporation

List of Data Sources List of Tables ##.

  • Genomics
  • United States
  • Market Size
  • GENOMICS
  • Difficulties In Distinguishing Clinically Meaningful Genomic Alterations

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Genomics
  • North America
  • United States
  • World
  • Market Size
  • ASIA PACIFIC GENOMICS BIOCHIPS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
  • GENOMICS MARKET IS FURTHER SEGMENTED INTO GENE EXPRESSION, SNP GENOTYPING AND OTHERS.

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine. The global biochips market is expected...

  • Genomics
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • BGI Genomics
  • Illumina

About Non-invasive Prenatal Testing Non-invasive prenatal screening is performed primarily by ultrasonography and serum testing from maternal plasma. Ultrasonography uses the clear tissue behind the infant’s neck to detect genetic defects. A fetus with abnormalities tends to accumulate more fluid. Hence, more clear space is detected...

  • Genomics
  • United States
  • World
  • Forecast
  • Illumina, Inc.
  • Shortage of trained healthcare professionals in genomics
  • Integration of genomic data directly into clinical workflows

About Gene Expression Gene expression functions as a key pillar of the molecular biology market as multiple molecular biology techniques have been used extensively to study gene expression and gene quantification. Molecular biology techniques such as polymerase chain reaction (PCR); nucleotide sequencing, including next-generation...

  • Genomics
  • World
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • 8.2 Investment in Genomics and Proteomics Research
  • GLOBAL - GENETIC TESTING MARKET (MILLION US$), 2010 - 2015

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics is a new class of diagnostic tests that identify molecular and genetic markers for an individual patient. These markers determine potential benefit from a specific therapy or risk of developing a specific...

  • Genomics
  • World
  • Forecast
  • bioMerieux S.A.
  • Cepheid

Perspective: Predicting Market Success in the Life Science Genomics Space In This PerspectiveSituational OverviewMarket Opportunities in Generating Genomics DataMarket Opportunities in Managing Genomics DataMarket Opportunities in Software Supporting Analysis of

  • Genomics
  • Forecast
  • AGILENT TECHNOLOGIES: PRODUCT SEGMENTATION BY REVENUE 2016
  • GROWTH IN BIOINFORMATICS SOFTWARE INDUSTRY

About Microarray Biochips Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. A microarray biochip is a that biochip on which various microarrays are assembled on a substrate that permits...

  • Genomics
  • World
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • Genomics
  • Genomics

This report studies the life science instruments and reagents market over the forecast period of 2017 to 2023. The life science instruments and reagents market is expected to grow at a high single digit CAGR to reach $81,325 million by 2023. The report covers all life instruments and associated reagents used in pharmaceuticals,...

  • Genomics
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • 7.3 BEIJING GENOMICS INSTITUTE
  • 9.3 BEIJING GENOMICS INSTITUTE

Next Generation Sequencing (NGS) Market The Global Next Generation Sequencing Market is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. Next generation sequencing, also known as high-throughput sequencing, is a DNA sequencing technology that has revolutionized genomic research. Due to its ability...

  • Genomics
  • North America
  • United States
  • World
  • Roche Group
  • Untitled
  • HORIZON DISCOVERY

“The genome editing/genome engineering market is projected to grow at a CAGR of 14.5%.” The global genome editing market is expected to grow at a CAGR of 14.5% to reach to USD 6.28 billion by 2022. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects,...

  • Genomics
  • Horizon Discovery
  • Integrated DNA Technologies, Inc.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • 6.9 EAGLE GENOMICS LTD.
  • 9.6 EAGLE GENOMICS LTD

Precision Medicine Market The global precision medicine market is expected to reach close to USD 40 billion by the end of 2016, gradually growing at an estimated CAGR of 10.3% by 2021. Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and...

  • Genomics
  • North America
  • United States
  • World
  • QIAGEN N.V.
  • 13.13 GENOMIC HEALTH
  • 9.12 GENOMIC HEALTH

Cancer Biomarkers Market The market for Global Cancer Biomarkers is highly dynamic. The Cancer Biomarkers market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016, at a CAGR of XX%. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers...

  • Genomics
  • North America
  • United States
  • World
  • Market Size
  • 10.2 BGI (BEIJING GENOMICS INSTITUTE)
  • November 2012

A decade has gone, since the first human genome has been sequenced and sequencing technology has come a long way from the time of introduction as Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was...

  • Genomics
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • 9.10 GENOMIC HEALTH INC.
  • FINANCIALS (IN USD MILLION)

Molecular Diagnostics Market The market was valued at USD 6 billion in 2015 and is expected to grow to USD 6.58 in 2016 and USD 9.53 billion by 2021, at a CAGR of 9.7%. Molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions,...

  • Genomics
  • North America
  • United States
  • World
  • Market Size
  • NUCLEIC ACID ISOLATION & PURIFICATION MARKET: REVENUE IN USD MILLION BY APPLICATION, GENOMIC
  • NUCLEIC ACID ISOLATION & PURIFICATION MARKET: REVENUE IN USD MILLION, BY APPLICATION, GENOMIC

The global nucleic acid isolation and purification (NAIP) market is estimated to reach approximately USD 5,300 million by 2023, at a CAGR of about 9% during the forecast period. This market is segmented based on technology, product, application, end user, and geography. In the segmentation based on technology, column-based purification has...

  • Genomics
  • United States
  • World
  • Forecast
  • Takara Bio Inc.